Neurocrine Biosciences Inc (NASDAQ:NBIX) - Share price - Overview

Stock Report

Neurocrine Biosciences Inc NBIX

Last Price
$103.22

Day Change
-1.32|-1.26%

As of 18/07/2018
16:48:31 EDT | USD
Minimum 15 Minutes Delay.

Last Close104.54
Day Range102.30 - 104.85
Mkt Cap9.28Bil
52-Wk Range46.50 - 106.26
Yield %-
ISINUS64125C1099
Volume458,497
P/E-86.74
P/S39.37
P/CF-164.99

Share Price

Financials
201520162017
More ...
Income Statement
Revenue19.7715.00161.63
Operating Income-94.20-147.37-131.36
Net Income-88.93-141.09-142.54
Basic EPS-1.05-1.63-1.62
Avg. Diluted Shares Outstanding848788
Balance Sheet
Current Assets384.07310.44554.92
Non Current Assets90.7154.64262.67
Total Assets474.79365.09817.59
Current Liabilities25.7230.4154.43
Total Liabilities---
Total Equity424.45314.88372.14
Cash Flow
Operating Cash Flow-38.00-106.18-94.33
Capital Expenditure-1.93-4.11-6.94
Free Cash Flow-39.93-110.29-101.27

In millions, except "Basic EPS". Currency is USD.

Company Profile

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

440
Key Stats
More ...
Price/Earning TTM-87.85
Price/Book25.78
Price/Sales TTM39.82
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-81.27
Net Margin % TTM-88.19
ROE TTM-41.50
Debt/Equity0.99
Dividends
PreviousLatest
More ...
Declared Datet.b.c.09/12/95
Ex-Divt.b.c.29/12/95
Paidt.b.c.t.b.c.
Amnt0.000.04
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.